Journal of Interventional Cardiology · 2019 · 22 citations · 28 references
MedicineCardiologyInternal MedicineClinical CardiologyHemodynamic ManagementInterventional CardiologyAcute Coronary SyndromesCoronary Artery DiseaseIschemic Heart DiseaseMyocardial Infarction ComplicationsPercutaneous Coronary InterventionC-reactive Protein TestingCardiovascular Risk MarkersCardiovascular Risk StratificationCoronary Physiologic AssessmentMyocardial Infarction Risk StratificationPercutaneous Coronary Intervention CareShock ClassificationShock Severity Classification
OBJECTIVE: Coronary slow/no reflow is not rare after successfully undergoing primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI), and shock index (SI) is an important factor for adverse cardiovascular prognosis. In this study, we are to explore whether SI is associated with coronary slow/no reflow in patients with AMI following primary PCI. METHODS: A total of 153 consecutive AMI patients undergoing primary PCI within 24 hours of symptom onset were included in this study. The participants were divided into normal flow group (n=124) and slow/no reflow group (n=29) according to cineangiograms recorded during the period of PCI. Cardiovascular risk factors, hematologic parameters, preoperative management of antithrombotic therapy, and baseline angiography were collected. RESULTS: SI, plasma glucose, white blood cells (WBC) and neutrophil count, neutrophil to lymphocyte ratio (PLR), high sensitivity C-reactive protein (hs-CRP), probrain natriuretic peptide (pro-BNP), and Killip classification on admission and thrombus burden on initial angiography were significantly different between patients with and without slow/no reflow. Multivariate analysis revealed that SI≥0.66, thrombus burden, and plasma glucose on admission were independent predictors for coronary slow/no reflow. Preoperative management of tirofiban therapy improves initial thrombolysis in myocardial infarction (TIMI). However, it has no effect on prognosis of slow/no reflow. CONCLUSION: Our findings demonstrated that slow/no reflow in patients with AMI following primary PCI was more likely associated with SI≥0.66, thrombus burden, and plasma glucose on admission. SI as a predictor for coronary slow/no reflow should be further confirmed in the following more large-scale and prospective studies. The clinical registration number is ChiCTR1900024447.
28
Itsuro Morishima, Takahito Sone, Kenji Okumura et al. · Journal of the American College of Cardiology · 2000 · 576 citations
Microvascular Obstruction and the No-Reflow Phenomenon After Percutaneous Coronary Intervention
Ronen Jaffe, Thierry Charron, Geoffrey Puley et al. · Circulation · 2008 · 407 citations · Full text
Medicine, Cardiology, Surgery +14
Lawrence Title, Peter M. Cummings, Karen Giddens et al. · Journal of the American College of Cardiology · 2000 · 332 citations
Atsushi Tanaka, Toshio Imanishi, Hiroki Kitabata et al. · European Heart Journal · 2009 · 185 citations · Full text